tetraethylammonium has been researched along with Prostatic Neoplasms in 6 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We conclude that, in prostate cancer epithelial cells, alpha1-ARs and m1-AChRs are functionally coupled to Ca2+-permeable DAG-gated cationic channels, for which TRPC1 and TRPC3 are the most likely candidates." | 1.32 | Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells. ( Lepage, G; Prevarskaya, N; Roudbaraki, M; Shuba, Y; Skryma, R; Sydorenko, V; Thebault, S, 2003) |
| "We conclude that VRACs in human prostate cancer epithelial cells are modulated via protein tyrosine phosphorylation." | 1.31 | Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line. ( Kostyuk, PG; Lemonnier, L; Mauroy, B; Prevarskaya, N; Shuba, YM; Skryma, R; Van Coppenolle, F, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sydorenko, V | 1 |
| Shuba, Y | 1 |
| Thebault, S | 1 |
| Roudbaraki, M | 1 |
| Lepage, G | 1 |
| Prevarskaya, N | 4 |
| Skryma, R | 4 |
| Fraser, SP | 1 |
| Grimes, JA | 1 |
| Diss, JK | 1 |
| Stewart, D | 1 |
| Dolly, JO | 1 |
| Djamgoz, MB | 1 |
| Skryma, RN | 1 |
| Prevarskaya, NB | 1 |
| Dufy-Barbe, L | 2 |
| Odessa, MF | 1 |
| Audin, J | 1 |
| Dufy, B | 2 |
| Van Coppenolle, F | 3 |
| Shuba, YM | 1 |
| Lemonnier, L | 2 |
| Kostyuk, PG | 1 |
| Mauroy, B | 1 |
| Rybalchenko, V | 1 |
| Legrand, G | 1 |
| Le Bourhis, X | 1 |
6 other studies available for tetraethylammonium and Prostatic Neoplasms
| Article | Year |
|---|---|
Receptor-coupled, DAG-gated Ca2+-permeable cationic channels in LNCaP human prostate cancer epithelial cells.
Topics: Base Sequence; Calcium Channels; Carbachol; DNA Primers; Electrophysiology; Evoked Potentials; Human | 2003 |
Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation.
Topics: 4-Aminopyridine; Animals; Blotting, Western; Calcium Channel Blockers; Cell Line, Tumor; Charybdotox | 2003 |
Potassium conductance in the androgen-sensitive prostate cancer cell line, LNCaP: involvement in cell proliferation.
Topics: Androgens; Apoptosis; Calcium; Cell Division; Elapid Venoms; Humans; Male; Membrane Potentials; Patc | 1997 |
Characterization of Ca(2+)-inhibited potassium channels in the LNCaP human prostate cancer cell line.
Topics: Adenocarcinoma; Calcium; Charybdotoxin; Elapid Venoms; Humans; Ion Channel Gating; Ion Transport; Ly | 1999 |
Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine | 2000 |
Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating.
Topics: Antineoplastic Agents; Binding Sites; Binding, Competitive; Calcium Channel Blockers; Cell Division; | 2001 |